Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches to topical therapy.

C H Smith1

  • 1Skin Therapy Research Unit, St John's Institute of Dermatology, St Thomas' Hospital, London, UK. catherine.smith@uhl.nhs.uk

Clinical and Experimental Dermatology
|December 21, 2000
PubMed
Summary

Topical corticosteroids for atopic dermatitis have side effects. New macrolide immunosuppressants and enzyme inhibitors offer potent alternatives with improved safety profiles, potentially changing treatment soon.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

BMJ open·2025
Same author

The Feeding-swallowing Impact Survey: Reference Values from a UK Sample of Parents of Children Without a Known or Suspected Feeding Disorder.

Dysphagia·2025
Same author

The management of severe eczema in pregnancy.

Clinical medicine (London, England)·2024
Same author

Integrative phylogenetic, phylogeographic and morphological characterisation of the Unio crassus species complex reveals cryptic diversity with important conservation implications.

Molecular phylogenetics and evolution·2024
Same author

Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Topical corticosteroids are effective for atopic dermatitis but have limiting side effects.
  • Current treatment options for atopic dermatitis are limited.

Purpose of the Study:

  • To review the efficacy and safety of emerging topical treatments for atopic dermatitis.
  • To discuss the potential of macrolide immunosuppressants and enzyme inhibitors as alternatives to corticosteroids.

Main Methods:

  • Review of current literature on topical treatments for atopic dermatitis.
  • Analysis of clinical data on ascomycin, tacrolimus, PLA(2) inhibitors, and PDE 4 inhibitors.

Main Results:

  • Topically active macrolide immunosuppressants show comparable potency to corticosteroids with fewer adverse effects.
  • Enzyme inhibitors (PLA(2) and PDE 4) are in early development and show promise as steroid-sparing agents.

Conclusions:

  • New topical therapies like macrolide immunosuppressants and enzyme inhibitors offer promising alternatives for atopic dermatitis management.
  • Further long-term safety data is needed for these agents.
  • The future of topical atopic dermatitis treatment is evolving with these novel therapeutic strategies.

Related Experiment Videos